Clinical trials
Recruiting Hidradenitis Suppurativa trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Peking Union Medical College | 2 |
| Sanofi | 2 |
| Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Second Xiangya Hospital of Central South University | 1 |
| Shanghai Huaota Biopharmaceutical Co., Ltd. | 1 |
| Shanghai Qilu Pharmaceutical Research and Development Center LTD | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hidradenitis Suppurativa | 12 |
| Arthritis, Rheumatoid | 1 |
| Dermatitis, Atopic | 1 |
| Pain | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.